Storage mite allergen extracts

PreclinicalBiologic

HHaukeland University Hospital

Storage mite allergen extracts is one of 11 biologic programs targeting Rhinitis. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

RhinitisActive, not recruiting

RhinitisPreclinical

Active, not recruiting

Competition

Competitive Landscape

10 competitors in Rhinitis

#DrugCompanyPhaseTrials

Prevacid

Takeda

Approved

1 2

Aspercreme Warming

AAveritas Pharma, Inc.

Approved

4 3

Xyzal

CChattem

Approved

1 4

Singulair

OOrganon and Co

Approved

1 5

Flovent

PParatek Pharmaceuticals Inc

Approved

1 6

Rhofade

KKenvue Brands

Approved

1 7

Xolair

Roche

Preclinical

—8

Flovent

PParatek Pharmaceuticals Inc

Preclinical

2 9

Clarinex

OOrganon and Co

Preclinical

—10

Allergen Immunotherapy

RRoxall Medicina España S.A

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Rhinitis1 trial

Nasal Provocation Testing in Occupational Rhinitis

Completed·HHaukeland University Hospital·N/A·NCT01436851·17 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Storage mite allergen extracts. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Storage mite allergen extracts compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Storage mite allergen extracts. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Haukeland University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: HHaukeland University Hospital

Storage mite allergen extracts

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Rhinitis1 trial

References

Drug Info

Quick Facts

Related News